Palatin Technologies Secures €5.5 Million Milestone for Retinal Disease Treatment with Boehringer Ingelheim #United_States #Boehringer_Ingelheim #Palatin_Technologies #Princeton #Retinal_Disease
0
0
0
0
Palatin Technologies Secures €5.5 Million Milestone for Retinal Disease Treatment with Boehringer Ingelheim #United_States #Boehringer_Ingelheim #Palatin_Technologies #Princeton #Retinal_Disease
Nanoscope Therapeutics to Showcase Vision Restoration Breakthroughs at Upcoming Eyecelerator and ARVO 2025 Events #United_States #Salt_Lake_City,_Utah #Nanoscope #Optogenetics #Retinal_Disease